» Articles » PMID: 32451439

ROCK-mediated Selective Activation of PERK Signalling Causes Fibroblast Reprogramming and Tumour Progression Through a CRELD2-dependent Mechanism

Abstract

It is well accepted that cancers co-opt the microenvironment for their growth. However, the molecular mechanisms that underlie cancer-microenvironment interactions are still poorly defined. Here, we show that Rho-associated kinase (ROCK) in the mammary tumour epithelium selectively actuates protein-kinase-R-like endoplasmic reticulum kinase (PERK), causing the recruitment and persistent education of tumour-promoting cancer-associated fibroblasts (CAFs), which are part of the cancer microenvironment. An analysis of tumours from patients and mice reveals that cysteine-rich with EGF-like domains 2 (CRELD2) is the paracrine factor that underlies PERK-mediated CAF education downstream of ROCK. We find that CRELD2 is regulated by PERK-regulated ATF4, and depleting CRELD2 suppressed tumour progression, demonstrating that the paracrine ROCK-PERK-ATF4-CRELD2 axis promotes the progression of breast cancer, with implications for cancer therapy.

Citing Articles

CAF-Associated Genes in Breast Cancer for Novel Therapeutic Strategies.

Naito K, Sangai T, Yamashita K Biomedicines. 2024; 12(9).

PMID: 39335478 PMC: 11428270. DOI: 10.3390/biomedicines12091964.


Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair.

Wu X, Zheng L, Reboll M, Hyde L, Mass E, Niessen H Nat Cardiovasc Res. 2024; 3(2):186-202.

PMID: 39196188 PMC: 11358006. DOI: 10.1038/s44161-023-00411-x.


Enhanced RHO-ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma.

Pittar A, Buckley E, Boyle S, Ibbetson S, Samuel M Cytoskeleton (Hoboken). 2024; 81(12):864-871.

PMID: 38979935 PMC: 11615837. DOI: 10.1002/cm.21894.


MOTAI: A Novel Method for the Study of O-GalNAcylation and Complex O-Glycosylation in Cancer.

Yue S, Wang X, Wang L, Li J, Zhou Y, Chen Y Anal Chem. 2024; 96(28):11137-11145.

PMID: 38953491 PMC: 11257061. DOI: 10.1021/acs.analchem.3c05018.


Molecular characterization of the ER stress-inducible factor CRELD2.

Hinaga S, Kandeel M, Oh-Hashi K Cell Biochem Biophys. 2024; 82(2):1463-1475.

PMID: 38753249 DOI: 10.1007/s12013-024-01300-1.


References
1.
Boudreau A, Vant Veer L, Bissell M . An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr. 2012; 6(3):236-48. PMC: 3427238. DOI: 10.4161/cam.20880. View

2.
Sakakura T, Suzuki Y, Shiurba R . Mammary stroma in development and carcinogenesis. J Mammary Gland Biol Neoplasia. 2013; 18(2):189-97. DOI: 10.1007/s10911-013-9281-9. View

3.
Gascard P, Tlsty T . Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016; 30(9):1002-19. PMC: 4863733. DOI: 10.1101/gad.279737.116. View

4.
Luo H, Tu G, Liu Z, Liu M . Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression. Cancer Lett. 2015; 361(2):155-63. DOI: 10.1016/j.canlet.2015.02.018. View

5.
Erez N, Glanz S, Raz Y, Avivi C, Barshack I . Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors. Biochem Biophys Res Commun. 2013; 437(3):397-402. DOI: 10.1016/j.bbrc.2013.06.089. View